Donald A Berry Selected Research

Donald A Berry Research Topics

Disease

63	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2002
53	Neoplasms (Cancer) 01/2022 - 02/2002
13	Leukemia 11/2012 - 02/2002
11	Pathologic Complete Response 12/2021 - 11/2005
5	Triple Negative Breast Neoplasms 12/2021 - 01/2015
4	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 07/2015
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 08/2013
4	Neoplasm Metastasis (Metastasis) 03/2021 - 11/2005
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2015 - 05/2007
3	Residual Neoplasm 11/2021 - 07/2016
3	Infections 01/2020 - 05/2007
2	Melanoma (Melanoma, Malignant) 01/2021 - 11/2012
2	Neutropenia 01/2015 - 05/2007
2	Thrombocytopenia (Thrombopenia) 01/2015 - 05/2007
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2011 - 05/2003
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2022
1	Neuroinflammatory Diseases 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022
1	Disease Progression 01/2022
1	Hyperglycemia 10/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Cognitive Dysfunction 01/2021
1	Dementia (Dementias) 01/2021
1	Edema (Dropsy) 01/2021
1	Adenocarcinoma 01/2021
1	Critical Illness (Critically Ill) 01/2020
1	COVID-19 01/2020
1	Lung Neoplasms (Lung Cancer) 12/2018
1	Hematologic Neoplasms (Hematological Malignancy) 04/2018

Drug/Important Bio-Agent (IBA)

19	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 02/2002
19	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 02/2002
18	Hormones (Hormone)IBA 01/2022 - 03/2003
18	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 03/2003
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2007
10	Pharmaceutical PreparationsIBA 01/2022 - 11/2012
9	Estrogen ReceptorsIBA 01/2018 - 03/2003
8	Fluorouracil (Carac)FDA LinkGeneric 10/2019 - 02/2002
7	human ERBB2 proteinIBA 01/2018 - 12/2009
6	Trastuzumab (Herceptin)FDA Link 11/2021 - 07/2015
5	Tamoxifen FDA LinkGeneric 07/2013 - 02/2002
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2006
4	Bevacizumab (Avastin)FDA Link 01/2021 - 03/2014
4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 10/2007
3	Methotrexate (Mexate)FDA LinkGeneric 10/2019 - 05/2003
3	Lapatinib (GW572016)FDA Link 11/2018 - 07/2015
3	Carboplatin (JM8)FDA LinkGeneric 07/2016 - 01/2015
3	AnthracyclinesIBA 04/2013 - 10/2007
3	Tumor Biomarkers (Tumor Markers)IBA 09/2012 - 07/2005
2	lecanemabIBA 05/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2021
2	Capecitabine (Xeloda)FDA Link 10/2019 - 05/2009
2	Messenger RNA (mRNA)IBA 11/2018 - 02/2016
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	PhosphoproteinsIBA 01/2022
1	Nerve Growth Factors (Neurotrophins)IBA 01/2022
1	olaparibIBA 12/2021
1	durvalumabIBA 12/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021
1	pertuzumabIBA 11/2021
1	Ado-Trastuzumab EmtansineIBA 11/2021
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	ganitumabIBA 10/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	AlbuminsIBA 03/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	COVID-19 VaccinesIBA 01/2020
1	tocilizumab (atlizumab)FDA Link 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	pembrolizumabIBA 01/2020
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2020
1	MK 2206IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 10/2019
1	Phenobarbital (Luminal)FDA Link 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	RNA (Ribonucleic Acid)IBA 11/2018
1	ribociclibIBA 04/2018
1	encorafenibIBA 04/2018
1	4- amino- 5- fluoro- 3- (5- (4- methylpiperazin- 1- yl)- 1H- benzimidazol- 2- yl)quinolin- 2(1H)- oneIBA 04/2018
1	sonidegibIBA 04/2018
1	infigratinibIBA 04/2018
1	NVP-BKM120IBA 04/2018
1	binimetinibIBA 04/2018
1	ceritinibIBA 04/2018

Therapy/Procedure

48	Therapeutics 12/2022 - 03/2003
21	Neoadjuvant Therapy 12/2021 - 04/2012
20	Drug Therapy (Chemotherapy) 11/2021 - 02/2002
13	Adjuvant Chemotherapy 01/2020 - 03/2003
4	Segmental Mastectomy (Lumpectomy) 12/2018 - 07/2013
4	Radiotherapy 12/2018 - 07/2013
2	Immunotherapy 01/2022 - 12/2018
2	Precision Medicine 03/2021 - 02/2012
2	Hematopoietic Stem Cell Transplantation 08/2011 - 08/2011
2	Combination Drug Therapy (Combination Chemotherapy) 06/2007 - 04/2003
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022
1	Investigational Therapies (Experimental Therapy) 11/2021